Sulfonic Acid Derivatives in the Production of Stable Co-Amorphous Systems for Solubility Enhancement

•Sulfonic acid derivatives enabled the production of stable co-amorphous systems by salification.•The solubility of olanzapine increased up to 145 times in the co-amorphous systems.•Regardless of sulphonic used, solvent evaporation promoted the highest increase in drug solubility.•Co-amorphous olanzapine was significantly more stable than the amorphous drug.•Co-amorphization of olanzapine with saccharin as a co-former resulted in systems more stable than with cyclamic acid or acesulfame. Co-amorphization is a promising approach to stabilize drugs in the amorphous form. Olanzapine, a poorly water-soluble drug was used in this study. Sulfonic acids (saccharin, cyclamic acid and acesulfame), free and in salt forms, were used as co-formers and compared with carboxylic acids commonly used in the preparation of co-amorphous systems. Several manufacturing techniques were tested, and the co-amorphous systems characterized by differential scanning calorimetry, X-ray powder diffraction, thermogravimetry and Fourier-transform infrared spectroscopy. Free sulfonic acids produced co-amorphous systems with the drug, unlike their salts. Spectroscopy data suggests the formation of salts between olanzapine and the sulfonic acids, used as co-formers. The co-amorphous system produced with saccharin by solvent evaporation, showed the most notable solubility enhancement (145 times). The stability of amorphous and co-amorphous olanzapine systems was assessed upon exposure to stress conditions during storage. Amorphized olanzapine readily reconverted back to the crystalline form while sulfonic acids:olanzapine co-amorphous were stable for up to 24 weeks in low/medium humidity conditions (11-75% RH). Results highlight the potential advantages offered by sulfonic acids as co-formers to produce stable and more soluble co-amorphous olanzapine. [Display omitted]